TGFBR1 and neoplasm: Taking advantage of immunocompetent Tgfbr1/Pten‐knockout HNSCC models, we observed restoration of effector T cells by targeting CD4+TIM3+ cells and CD8+TIM3+ cells and decreasing MDSCs in tumor microenvironment and peripheral environment.